538 related articles for article (PubMed ID: 28625749)
1. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
2. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
3. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the therapeutic efficacy of
Csikos C; Képes Z; Fekete A; Vágner A; Nagy G; Gyuricza B; Arató V; Kárpáti L; Mándity I; Bruchertseifer F; Halmos G; Szikra D; Trencsényi G
Int J Pharm; 2023 Sep; 644():123344. PubMed ID: 37634663
[TBL] [Abstract][Full Text] [Related]
5. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
6. Comparative preclinical evaluation of
Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I
J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651
[TBL] [Abstract][Full Text] [Related]
7. In Vivo evaluation of newly synthesized
Kálmán-Szabó I; Képes Z; Fekete A; Vágner A; Nagy G; Szücs D; Gyuricza B; Arató V; Varga J; Kárpáti L; Garai I; Mándity I; Bruchertseifer F; Elek J; Szikra D; Trencsényi G
J Pharm Biomed Anal; 2023 May; 229():115374. PubMed ID: 37001274
[TBL] [Abstract][Full Text] [Related]
8. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
9. Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity.
Bapst JP; Froidevaux S; Calame M; Tanner H; Eberle AN
J Recept Signal Transduct Res; 2007; 27(5-6):383-409. PubMed ID: 18097939
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.
Kobayashi M; Kato T; Washiyama K; Ihara M; Mizutani A; Nishi K; Flores LG; Nishii R; Kawai K
PLoS One; 2019; 14(3):e0213397. PubMed ID: 30901323
[TBL] [Abstract][Full Text] [Related]
11. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
McQuade P; Miao Y; Yoo J; Quinn TP; Welch MJ; Lewis JS
J Med Chem; 2005 Apr; 48(8):2985-92. PubMed ID: 15828837
[TBL] [Abstract][Full Text] [Related]
12. Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.
Cantorias MV; Figueroa SD; Quinn TP; Lever JR; Hoffman TJ; Watkinson LD; Carmack TL; Cutler CS
Nucl Med Biol; 2009 Jul; 36(5):505-13. PubMed ID: 19520291
[TBL] [Abstract][Full Text] [Related]
13. Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
von Hacht JL; Erdmann S; Niederstadt L; Prasad S; Wagener A; Exner S; Beindorff N; Brenner W; Grötzinger C
PLoS One; 2019; 14(6):e0217883. PubMed ID: 31163066
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-Targeting Property of Y-90-Labeled Lactam-Cyclized α-Melanocyte-Stimulating Hormone Peptide.
Xu J; Yang J; Gonzalez R; Fisher DR; Miao Y
Cancer Biother Radiopharm; 2019 Nov; 34(9):597-603. PubMed ID: 31644317
[No Abstract] [Full Text] [Related]
15. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
Wei L; Zhang X; Gallazzi F; Miao Y; Jin X; Brechbiel MW; Xu H; Clifford T; Welch MJ; Lewis JS; Quinn TP
Nucl Med Biol; 2009 May; 36(4):345-54. PubMed ID: 19423001
[TBL] [Abstract][Full Text] [Related]
16. Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.
Guo H; Gallazzi F; Miao Y
Bioconjug Chem; 2012 Jun; 23(6):1341-8. PubMed ID: 22621181
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Melanoma Imaging with
Zhang C; Zhang Z; Lin KS; Pan J; Dude I; Hundal-Jabal N; Colpo N; Bénard F
Theranostics; 2017; 7(4):805-813. PubMed ID: 28382155
[TBL] [Abstract][Full Text] [Related]
18. Al
Palangka CRAP; Hanaoka H; Yamaguchi A; Murakami T; Tsushima Y
Ann Nucl Med; 2019 Oct; 33(10):733-739. PubMed ID: 31297699
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting.
Yang J; Xu J; Cheuy L; Gonzalez R; Fisher DR; Miao Y
Mol Pharm; 2019 Apr; 16(4):1694-1702. PubMed ID: 30763112
[TBL] [Abstract][Full Text] [Related]
20. Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.
Ren G; Liu S; Liu H; Miao Z; Cheng Z
Bioconjug Chem; 2010 Dec; 21(12):2355-60. PubMed ID: 21073170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
